Cheol Park - Genic Chief Executive Officer, Director

123330 Stock  KRW 19,860  570.00  2.95%   

CEO

Cheol Park is Chief Executive Officer, Director of Genic Co since 2018.
Age 46
Tenure 6 years
Phone82 3 1725 5600
Webhttps://www.genic21.com

Genic Management Efficiency

The company has return on total asset (ROA) of (0.02) % which means that it has lost $0.02 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (18.3566) %, meaning that it generated substantial loss on money invested by shareholders. Genic's management efficiency ratios could be used to measure how well Genic manages its routine affairs as well as how well it operates its assets and liabilities.
Genic Co has accumulated 10.3 B in total debt with debt to equity ratio (D/E) of 1.06, which is about average as compared to similar companies. Genic has a current ratio of 1.9, which is within standard range for the sector. Debt can assist Genic until it has trouble settling it off, either with new capital or with free cash flow. So, Genic's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Genic sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Genic to invest in growth at high rates of return. When we think about Genic's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 2 records

CEO Age

Youngho LeeChoil Aluminum
58
Yeong SongDaejung Chemicals Metals
41
Genic Co., Ltd. researches, develops, manufactures, and sells hydrogel mask packs in South Korea and internationally. The company was founded in 2001 and is based in Seongnam-si, South Korea. Genic is traded on Korean Securities Dealers Automated Quotations in South Korea. Genic Co (123330) is traded on KOSDAQ in Korea and employs 204 people.

Management Performance

Genic Leadership Team

Elected by the shareholders, the Genic's board of directors comprises two types of representatives: Genic inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Genic. The board's role is to monitor Genic's management team and ensure that shareholders' interests are well served. Genic's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Genic's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jeong Han, Internal Auditor
Hyunho Yoo, Chief Officer
Jong Kim, Assistant Managing Director
Kim Cheol, Managing Director
SungEun Kim, Managing Director
KangDon Oh, Managing Director
Cheol Park, Chief Executive Officer, Director
Yeong Shin, Internal Auditor
Seong Kim, Director

Genic Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Genic a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Genic

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Genic position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genic will appreciate offsetting losses from the drop in the long position's value.

Moving against Genic Stock

  0.36054180 MEDICOXPairCorr
The ability to find closely correlated positions to Genic could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Genic when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Genic - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Genic Co to buy it.
The correlation of Genic is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Genic moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Genic moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Genic can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Genic Stock

Genic financial ratios help investors to determine whether Genic Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Genic with respect to the benefits of owning Genic security.